July 20, 2007:  Financial Results

Q1 FINANCIAL RESULTS

Ipca Laboratories Ltd. (Ipca) has posted a net total income of Rs.247.22 crores for the quarter ended 30th June, 2007 as against Rs.222.04 crores in the same quarter of the previous financial year, a growth of 11%. Export Sales for the quarter is Rs.109.30 Crores as against Rs.104.83 crores in the same quarter previous year.

The Net Profit for the quarter is up by 43% to Rs.34.72 crores as against Rs.24.34 crores in the same quarter previous year. The diluted Earnings Per Share works out to Rs.13.79 per share of Rs.10/- each.

During the Quarter:

Ipca has started a new domestic marketing division 'ALTUS' for marketing a basket of oral and injectable antibiotics catering to the needs of intensivists, both surgical and non-surgical, with a portfolio of 8 brands.

Ipca, through its marketing partner, has entered US generic market with one formulation from 3 ANDAs granted by US FDA out of 8 ANDAs filed.

1st Quarter at a glance

 

(Rs. Crores)
1st Quarter ended	30.06.2007	30.06.2006	Growth
Net Total Income	247.22	222.04	11 %
Export Income	109.30	104.83	4%
Profit Before Tax	43.87	29.94	47%
Net Profit	34.72	24.34	43%
Earnings per share (Rs.)	13.79	9.74	42%

Ipca Laboratories is a backward integrated, fast growing pharmaceutical major, with a strong thrust on exports. Exports to over 110 countries, now account for nearly half of Company's income.

Premchand Godha
Managing Director

Also see: Unaudited Financial Results.

Back